用于阿尔茨海默氏症疾病分类的级联多模组混合变压器,数据不完整
Linfeng Liu1, Siyu Liu2, Lu Zhang3
1Queensland Brain Institute, The University of Queensland, Australia.
NeuroImage
|July 8, 2023
概括
本研究介绍了多模组混合变压器 (3MT),一种用于疾病分类的新型深度学习模型. 3MT有效地处理缺失的多模式数据,改善阿尔茨海默氏症 (AD) 等疾病的准确性.
科学领域:
- 人工智能在医学中的应用
- 机器学习用于医疗保健
- 神经科学和医学成像学
背景情况:
- 准确的医疗分类依赖于多模式数据,但现有模型在缺少数据的情况下扎,导致显著的不足利用.
- 深度学习的性能受到标记医疗图像的稀缺性所阻碍,特别是当模式不完整时.
- 需要灵活的多模式方法来处理不同临床环境中缺少的数据.
研究的目的:
- 介绍多模组混合变压器 (3MT),一种新型的深度学习模型,旨在使用多模组数据进行疾病分类.
- 开发一种有效处理缺失模式的方法,确保充分利用数据.
- 评估3MT在分类阿尔茨海默病 (AD) 和预测轻度认知障碍 (MCI) 转换方面的表现.
主要方法:
- 介绍了多模组混合变压器 (3MT),一种基于变压器的疾病分类模型.
- 采用了一种新的级联模式变压器架构,并采用交叉注意力来整合多模式信息.
- 实施了一种独特的模式退出机制,以提高对缺失数据的稳定性和独立性.
主要成果:
- 3MT在阿尔茨海默氏病神经成像计划 (ADNI) 数据集上展示了最先进的性能,用于阿尔茨海默氏病分类和MCI转换预测.
- 该模型在澳大利亚成像生物标志物和生活方式老龄化 (AIBL) 旗舰研究数据集上取得了高性能,即使缺少数据.
- 模式抛弃机制确保了在缺少模式的场景中充分利用数据.
结论:
- 3MT为多模式疾病分类提供了一种多功能解决方案,能够充分处理缺失数据的场景.
- 该模型混合任意数量的模式和特征类型的能力提高了其适用性.
- 3MT代表了利用不完整的多模式数据来改善医疗分类和预测的重大进步.
相关概念视频
Alzheimer's Disease: Overview
527
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
527
Multi-input and Multi-variable systems
132
Cruise control systems in cars are designed as multi-input systems to maintain a driver's desired speed while compensating for external disturbances such as changes in terrain. The block diagram for a cruise control system typically includes two main inputs: the desired speed set by the driver and any external disturbances, such as the incline of the road. By adjusting the engine throttle, the system maintains the vehicle's speed as close to the desired value as possible.
In the absence...
In the absence...
132
Alzheimer's Disease: Treatment
220
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
220


